China Universal Asset Management Company’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

China Universal Asset Management Company’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,122	Closed	-$2.27K	–	495
2023 Q3	$2.27K	Buy	2,122 +1,042	+96%	+$2.16K	﹤0.01%	428
2023 Q2	$2.8K	Sell	1,080 -32	-3%	-$114	﹤0.01%	409
2023 Q1	$4.54K	Buy	1,112 +282	+34%	+$1.3K	﹤0.01%	374
2022 Q4	$4.17K	Buy	830 +78	+10%	+$489	﹤0.01%	316
2022 Q3	$10K	Buy	+752	New	+$11.4K	﹤0.01%	211

Other funds holding NGM

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

China Universal Asset Management Company's NGM Position: Q4 2023 in Review

China Universal Asset Management Company sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q4 2023, closing a stake of 2,122 shares — an estimated $2.27K sold.

China Universal Asset Management Company first reported a position in NGM in Q3 2022 and held it in 5 quarters. The position peaked at $10K in Q3 2022. 83 funds tracked by Wall St. Rank hold NGM as of Q4 2023.

China Universal Asset Management Company reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
China Universal Asset Management Company sold 2,122 NGM Biopharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $2.27K.
China Universal Asset Management Company first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
China Universal Asset Management Company's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $10K in Q3 2022.
83 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.